13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up.
Amir RadSveinung Wergeland SørbyeTormod BrennSweta TiwariMaja-Lisa LøchenFinn Egil SkjeldestadPublished in: International journal of environmental research and public health (2023)
We observed significantly higher referral rates and CIN3+ detection rates in young women with ASC-US/LSIL when the HPV DNA test was used at triage. The mRNA test was as functional in cancer prevention, with considerably less healthcare utilization.